Informatics

Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School  Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive. ...

OptraSCAN was recently recognized by Frost and Sullivan with a Global Telepathology Enabling Technology Leadership Award. And why shouldn't they be recognized -- I think they are hitting on one of the key market segments that is largely...

“Crosswalk Insight™: Oncology” enhances Inspirata’s Digital Pathology Cockpit by providing access to Genomic Profiles, FDA-Approved Targeted Therapies, Immunotherapies and Clinical Trials to enable pathologists to make more precise...

Potential new technology here that may limit number of breast biopsies previously deemed "unnecessary" using artificial intelligence to aid screening with mammography with tumor protein expression. Perhaps as many as 20% of breast biopsies...

Published August 29, 2016 By Simon Häger, Product Manager Sectra Digital Pathology Solution Although most pathology departments have not yet made the transition to digital, many are actively evaluating the business case. Why? Most...

Interesting press release from Glencoe Software and ZEISS this morning. ZEISS is commissioning Glencoe to do custom work that is being made available to the whole community for free. An interesting approach to the whole question of open data...